Managers

Nexus Venture Partners raises $353.5 mln toward venture-capital fund

Nexus Venture Partners has raised $353.5 million toward a fifth venture-capital fund, according to a filing with the SEC.

Former FDA Commissioner Gottlieb returns to NEA as special partner

April Dashboard: Unicorn IPOs and other exits keep surging

Contrarian investing in venture capital today

Inhibrx to secure $40 mln

Viking Global Investors has agreed to provide $40 million to La Jolla, California-based Inhibrx, a biotech firm. Evercore was financial adviser to Inhibrx on the deal.

Locana snags $55 mln Series A

San Diego-based Locana Inc, a RNA-targeting gene therapy company, has raised $55 million in Series A financing. ARCH Venture Partners led the round with participation from other investors that included Temasek, Lightstone Ventures, UCB Ventures and GV.

Locana snags $55 mln Series A

San Diego-based Locana Inc, a RNA-targeting gene therapy company, has raised $55 million in Series A financing. ARCH Venture Partners led the round with participation from other investors that included Temasek, Lightstone Ventures, UCB Ventures and GV.

NFX doubles down on seed with $275 mln second fund

Horsley Bridge Partners is raising a $1.6 bln venture capital fund of funds

Horsley Bridge Partners is raising a $1.6 bln venture capital fund of funds